In the latest study, published by researchers from the University of California at Berkeley, the University of Texas, and GenEdit, have adapted CRISPR-Gold technology in order to treat autistic symptoms in mice. Beating the Autistic Odds with CRISPR One of the major highlights of the new research is the fact that CRISPR-cas9 could be a way to edit certain genes that relate to fragile X syndrome, which is a single-gene disorder frequently connected with autism, and autistic symptoms were improved on. Research provides additional evidence that conveyance of CRISPR-based therapeutics may be effectively accomplished via gold nanoparticles. Mutations in the FMR1 gene is the cause of Fragile X syndrome. This gene plays a key role in encoding the protein, FMRP, the regulator in the production of different proteins and contributes markedly to the development of synapses. Most of the time Fragile X occurs because of a mutation, which results in the enlargement of a part of the